Millipore Sigma Vibrant Logo
Ask us a question
BioContinuum Platform for Next Generation Bioprocessing

BioContinuum™ Automation & Analytics Platform

Next-Generation Bioprocessing Monitoring to Enable Smart Data Management and Analysis

As industry 4.0 principles are applied to and adopted in the biotech environment — also known as Biopharma 4.0 or Bioprocessing 4.0 — innovative, digital technologies and approaches typically not used in the drug manufacturing landscape emerge.

The convergence of disciplines such as advanced bioprocessing technologies with software, automation and analytics, the Internet of Things (IoT), machine learning (ML), virtual or augmented reality (VR/AR), digital twins and artificial intelligence (AI) is pushing boundaries and unlocking unprecedented possibilities to transform drug production.

Over the next 10 years, at least 35% of new molecules will incorporate intensified process technologies. With connected and continuous processing on the horizon, each batch will produce in excess of 1 billion data points per batch, necessitating the implementation of advanced digital tools for enhanced process control, data and process analytics, and faster decision making.


Webinars


Articles


Related Resources

Convergent Bioprocessing


Making Data Work: Leveraging data for better outcomes.


Josh Hays – Interphex presentation – Beyond Bioprocessing 4.0, the convergence of IT, OT and processing technologies.


Related Products: